Dow Inc. (DOW) Earnings Call Transcript & Summary

March 10, 2020

New York Stock Exchange US Materials Chemicals conference_presentation 38 min

Earnings Call Speaker Segments

Operator

operator
#1

Welcome. Thank you for standing by. This call is for JPMorgan Chase & Company personnel only. If you're not an employee or a consultant of JPMorgan Chase & Company, please disconnect at this time. [Operator Instructions] I'd like to inform all parties that today's conference is being recorded. If you have any objections, you may disconnect at this time. I'd now like to turn the conference over to Jeff Zekauskas. Thank you. You may begin.

Jeffrey Zekauskas

analyst
#2

Hi, good morning. This is a public conference call. I'd like to welcome everyone this morning to the JPMorgan Virtual Industrials Conference. We changed the format of our 2020 conference from an in-person format to a virtual one in the interest of health and safety. And so thank you very much for taking the time to attend this morning. It's my pleasure to introduce Howard Ungerleider, the Chief Financial Officer of Dow Chemical. Howard is a 30-year Dow veteran with extensive experience, both on the business side of Dow and on the financial side. He's managed its plastics businesses for years as well as it's more differentiated assets. Howard will make a brief presentation, and then Howard and I will conduct a fireside chat. Howard?

Howard Ungerleider

executive
#3

Jeff and everybody, good morning. And Jeff, thanks for clarifying that this is an open to the public call. So if you're not a JPMorgan employee or customer, please stay on the line. This is a public call. But thanks, Jeff, good morning to you. Good morning to the JPMorgan team. And really, thanks to everybody for the opportunity to speak today. As Jeff said, before we jump into questions, I'd like to just provide a brief update on our priorities and the progress we've made against them. I'll reference some slides, and you can find those slides in the Investors section of Dow's website. It's under the Events and Presentations page. Let me just jump right in. Beginning on Slide 2, I'd like to provide an update on our progress against the priorities and targets that we laid out to shareholders at our Investor Day in 2018. We have continued to maintain our focus on these priorities, consistently delivering progress against the milestones and targets every quarter, doing what we said we would do. On Slide 3, you can see the progress we've made on each of our priorities since spin. We successfully executed and started up all of our Wave 1 growth projects, and these investments contributed approximately $250 million of EBITDA in 2019. We also followed through on prioritizing low-risk incremental growth projects. For example, we completed 16 silicone debottlenecks last year, and we've more than 10 already identified for 2020. We advanced our Industrial Solutions investments in glycols, ethers and alkoxylates capacity on the Gulf Coast. We also progressed our incremental ethylene capacity add on the Gulf Coast. And recently, on the fourth quarter call, we announced a quick win ethylene addition in Western Canada as well. Our focus on disciplined capital allocation and cash generation is also producing results. Last year, we paid down more than $3 billion of debt, and we pursued opportunistic liability management such that our next major maturity is not due until the second half of 2023. We've been proactive on adjusting our CapEx spending to the realities we see in our end markets. And last year, we generated $5.7 billion of cash from operations, and we significantly improved our EBITDA to cash from ops conversion in 2019 as well. We also delivered against our synergy and stranded cost targets. We further rightsized our cost structure by completing our nearly $1.4 billion cost synergy program, and we achieved more than $160 billion -- $160 million, excuse me, of stranded cost savings. A best owner mindset continues to underscore everything that we do, and we completed several actions to increase transparency and drive a culture of benchmarking. To that end, we shifted our primary profit metric from EBITDA to EBIT. We disclosed key product capacities across our enterprise. We implemented a market-based ethylene transfer pricing internally. We completed several incremental footprint cleanup transactions in 2019. This year, we've now added cash flow as a metric on our annual incentive plan. And today, we're providing a benchmarking update, which I'll summarize in a moment. We achieved all of these things in spite of challenging macroeconomic and end market conditions in 2019. Now turning to Slide 4. I'd like to just take a moment to highlight the work we've done to ensure a strong and flexible capital structure, which remains a critical element to our long-term success. One of the foundational things we've done is to ensure we maintain a strong and diverse liquidity position. At the end of 2019, we had more than $11 billion of liquidity coming from multiple sources. Our near-term debt profile is very manageable as a result of our deleveraging and liability management actions. Our latest activity happened just a few weeks ago. We returned to Europe with our first eurobond in several years. We issued EUR 2.25 billion at a weighted average coupon of about 1%. We immediately used the proceeds in a debt-neutral way to pay down existing debt, including the make-whole of the USD 1.25 billion, 3% notes due in 2022, and we paid down $750 million on the outstanding term loan. And I would say, not only was this prudent liability management, but our timing allowed us to refinance debt at a lower coupon, leading to annual interest expense savings of $40 million. Now when you add that to the total deleveraging actions we already took last year, we anticipate a total interest expense savings of approximately $90 million in 2020 versus 2019. Looking ahead, we'll continue to be opportunistic in managing our debt towers to preserve our financial strength and our flexibility. Moving to Slide 5. You heard clearly on our fourth quarter earnings call that we remain focused on generating free cash flow through operational cash flow improvements, driving higher cash flow conversion and also pursuing several nonoperational cash flow items as well. Our base case shown here highlights approximately $4 billion of free cash flow potential in 2020. We plan to deploy our free cash flow in a balanced way, aligned with our top priorities. The dividend remains our #1 priority. We're currently on the high side of our capital structure targets, so deleveraging continues to also be a top priority as well. We'll continue to, of course, evaluate additional CapEx investments and lower-risk, faster-payback opportunities where available and we'll also return additional capital to shareholders. At a minimum this year, we plan to do share repurchases to cover dilution, which is in the $200 million range. Further cash optionality of approximately $1 billion could also come from several nonoperational items that are in progress. Any funds from these opportunities will also be used in a balanced way between deleveraging and returns to shareholders. The bottom line is we're confident in our ability to deliver against our disciplined financial playbook, and we will continue to deploy free cash flow in a manner that balances actions to strengthen our credit profile, enhance our financial flexibility and reward our owners. Turning to Slide 6. As you can see and hopefully, have heard from us repeatedly over the past year, we continue to be focused on the playbook we've outlined for investors. At our Investor Day in 2018, we discussed our drive for an internal culture of benchmarking in order to understand and strengthen our relative competitive positions, and we committed to share our progress with shareholders on a periodic basis. Today, I'm pleased to bring forward our benchmarking update, which summarizes our performance versus our peer group for the full year 2019. We're providing an update against the same metrics and benchmark peer set that we shared at Investor Day in 2018 to maintain both transparency and consistency. You'll find a comprehensive benchmarking update within the slide presentation, which is available on Dow's investor website. For the sake of time, I'll focus my comments this morning on a few key takeaways. First, we see that Dow outperformed our peer set in most instances, and we made good progress to narrow our gaps and/or extend our advantage over the peer set. Dow's Packaging & Specialty Plastics segment outperformed the benchmark across all measures. Cash conversion and SARD outperformed peers across all 3 segments as well. EBITDA growth was above benchmark in 2 of our 3 segments in Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure. EBITDA margins were also above benchmark in 2 of 3 segments, Packaging & Specialty Plastics and Performance Materials & Chemicals. And second, as you'll see in the benchmarking slides, Dow's polyolefin margins stood out from the pack. In 2019, we showed our margins to be both stickier and more resilient than our competitors, driven by several factors: our industry-leading feedstock flexibility; our unique cost advantage positions, including the U.S. Gulf Coast, Western Canada and Argentina, and even in a region like Europe, we can see the benefits of our asset capability and feedstock flexibility there as well; our fully integrated position from cost-advantaged feedstocks to a suite of polyolefins, elastomers and functional polymers; and finally, our product, market and application portfolio, which is differentiated by Dow's material science capabilities, evidenced by our ability to grow volume year-over-year and every quarter of last year. To wrap things up, I am very proud of the progress that team Dow has made in the past 1.5 years. We've continued to deliver on our strategic, operational and financial playbook that we outlined for investors, and our actions have enabled a stronger and a more competitive Dow. Now before we move into the Q&A, I'd like to address a couple of issues that are likely on investors' minds, COVID-19 and the real-time change that we saw yesterday in oil prices. Let me first address the coronavirus implications. First and foremost, on the COVID situation, our hearts go out to all of the communities and families around the world who are dealing with the immediate impacts of this issue. On the Dow side, our teams continue to respond admirably. All of our people are safe. The vast majority of our plants in China are running. A few are still running at reduced rates to balance with demand and logistics limitations. The Dow team has done a great job managing through this with employees, customers and suppliers. Given that we have assets on the ground in China, and we have seen direct top and bottom line impacts since Chinese New Year. In the first quarter, we've been running at about a 20% to 30% lower sales level in China than typical or about a $400 million headwind to sales. The lost variable margin on that translates to about $100 million direct bottom line EBITDA impact in China. As the virus has spread further and continued to upset supply chains around the world, we do expect some additional bottom line impact on top of that, which I would say are difficult to quantify at this time. However, if I had to size the total impact of COVID on our first quarter based on what I know today, both the impact in China and the knock-on impacts around the world, I would range the total impact to Dow in the first quarter in the $200 million range on EBITDA. Now this is clearly a dynamic situation, but I would say the good news is that the cases in China, and actually, now in South Korea as well, have been ramping down, in China for the last couple of weeks, in South Korea for approximately a week. And China is in the process of getting back to more normalized demand levels. Turning to the oil changes. If the current pricing scenario persists, it will likely have an impact on several of our chains and our JVs. In spite of these challenges, we feel very good about our absolute position on the cost curve and our benchmarking that we published this morning has proven our differentiation once again versus our peers. While the world has clearly thrown up some new headwinds, we're no stranger to managing risks. And in fact, that's the very reason we've taken the steps we have in the past few years, to be prepared for market uncertainties. Dow is well positioned for a variety of reasons. We have substantial absolute cost-advantaged assets, not just in the U.S. Gulf Coast but also in Canada and Argentina. We have industry-leading feedstock flexibility, which allows us to maneuver quickly as market dynamics change, giving us an advantage over our competitors. Our business portfolio is more consumer-driven, which gives us a level of resilience as we are tied to end markets that have held up better through the uncertainties. And again, our benchmarking data proves that out from last year. We have incredible breadth and depth in our core end markets and geographies, which gives us the reach and the capabilities to moderate these types of impacts. And we continue to drive a culture of benchmarking along with the best owner mindset that pushes our portfolio towards best-in-class performance in order to continue to stay ahead of our competition. And in terms of financial strength, we have purposely built our balance sheet. And as I mentioned earlier, no significant maturity is coming to until the back half of 2023. Free cash flow generation has continued to exceed the same quarter last year despite the lower earnings. And please don't forget that working capital, especially at these lower hydrocarbon values, should become a significant source of cash as well. And as I mentioned earlier also, we are working on several nonoperational cash inflows also. In short, our financial and operating playbook has significant flexibility to adjust to these headwinds. We have the operating levers in place to act quickly so you'll continue to see Dow act proactively to navigate the current environment. With that, Jeff, let's go to the Q&A.

Jeffrey Zekauskas

analyst
#4

Okay. Thank you for that very comprehensive introduction, Howard. You spoke about perhaps Dow suffering a $200 million penalty in the first quarter from the coronavirus, half of that being in China. Does that mean that your European operations really haven't been touched so much yet? And could you comment on the state of European demand, given the spread of the virus in Italy?

Howard Ungerleider

executive
#5

Yes, I would say your comment is more or less correct, Jeff. I mean, our assets, our big assets in Europe are in the Netherlands, in Germany and in Spain. So in Italy, we do have some smaller assets. We do have some assets that are in the country, and so those are going to be hampered, probably more from a demand perspective. Just like what we saw in China, we really were able to get our employees to the assets and running after Chinese New Year as soon as the government lifted the restrictions. We don't have any assets in the Hubei province. But I would imagine, and the reason why I frame the impact of about $100 million in China, and I'm assuming about $100 million in the rest of the world is because of some of those knock-on impacts, the China products as raw materials around the world. We do have some assets in Italy, and so that likely has some impact. And I think in terms of the indirect impact on demand. I mean, your honest guess is as good as mine. But I would say we're seeing about 0.5 point knock off at GDP. Some of the more bearish cases suggest maybe a full point knockoff of global GDP for the quarter. So I think that's kind of the range that we're looking at, and that's how I size that $200 million. But to the point that I made in my opening, it is a dynamic situation, but I take comfort in that demand in China is coming back. I was talking to Mauro Gregorio who runs our silicones business early this morning and our order book in Consumer Solutions for China in the month of March is well ahead of a normal March. And so that would that would signal more of a V-shaped recovery as they continue to ramp down. And now South Korea's cases for 5 or 6 days in a row are trending down as well. So that's another good data point.

Jeffrey Zekauskas

analyst
#6

So it seems that Asian demand is now recovering a little bit. Investors get nervous when they look at petrochemical companies in times that have so much energy, price fluctuation and volatility in demand. How do you see the trough earnings of Dow Chemical? You had a very, very strong year in 2019. And I think people fear that if the economy is quite weak, maybe this would look something like a trough year. How would you view something like that, Howard?

Howard Ungerleider

executive
#7

So Jeff, when we did all the capital structure work preparing for the spin-out of the new Dow, we did a range of Monte Carlo simulations with margins compressing, with economic recession, with trough margins. And really, the range of EBITDA outcomes for the portfolio as we spin out, on the low side, was about $6 billion of EBITDA, and on the high side was $13 billion of EBITDA. That's really the range of outcomes on a Monte Carlo -- multiple Monte Carlo simulation basis. So if you want to say, what would the downside case be? You could say $6 billion. I don't know off the top of my head where your trough number is. There's a couple of analysts that have a number out there that's a little bit lower in the $5.5 billion range. But I would say that's in line with all of the work that we get for capital structure.

Jeffrey Zekauskas

analyst
#8

When you think about the trough earnings of Dow, Howard, do you really locate the trough against an oil price? In other words, do you say, "Well, the trough earnings of Dow are at this level if oil is at $55 or $45 or $35?" Or is there another way that you do it when you get to your $6 billion number?

Howard Ungerleider

executive
#9

You've been covering the sector for a long time, and I've been here, as you mentioned in the opening, 30 years. I would say, oil is one factor, but really, supply-demand overall is a more important factor. So certainly, when oil goes down, product prices typically go down. But it really will depend on supply-demand fundamentals around the world on whether your margins are able to expand or contract. I can show you historical data that says when oil has been $30, we've had peak margins, and I can show you when oil's at $110 and we've had trough margins. So yes, I mean, look, at down-shock that we saw yesterday, our product price is likely -- naphtha as, you know, more than 50% of the world's crackers are naphtha-based. Naphtha historically does trade with oil. So as oil moves off, if you believe naphtha -- if you believe oil is going to stay low now, I mean, it's up 8% or 9% earlier this morning before we jumped on our call, so we'll see where everything settles out. Let's not forget, 30 days ago, it was -- it had a 5 handle in front of it. And I would say, when you look historically, with these kinds of shocks, when oil has dropped at this kind of magnitude, probably 70% or 80% of the time in history when that's happened, oil in the next 12 months has moved back up 30% or 40%. So -- but yes, to answer your direct question, oil will be a contributor to our revenue, so our revenue will go down. It's not necessarily the only factor that will impact our margins. It really comes down to demand, and what do you think of global GDP and even more importantly, what do you think about industrial production and then what do you think about the inventory destocking or restocking. I would say, when we ended last year -- last year was, I would call it an 11-month of demand year. January started out very strong, better than our expectations. And then we really saw the coronavirus or the COVID-19 impact, which took a little bit of the demand wind out. But I would say there's a reasonable likelihood that once the world gets through the virus, you'll get back to a normalized demand and margins, in theory then, could expand from here.

Jeffrey Zekauskas

analyst
#10

Sort of the offset to the pressure from oil prices is that ethane prices and propane prices in the United States have moved lower. Have you shifted your feedstock slate at all? Or are you pretty much trying to produce ethylene with this much ethane as you can?

Howard Ungerleider

executive
#11

Well, I would say, your first point, I think, is very valuable and one that I don't think the market -- when you look at what happened yesterday, I don't think the market's pricing in any of that thinking. So clearly, naphtha does move with oil. Propane typically does move with naphtha, and then propane does set kind of a range for ethane. So if you believe that, that lower oil is going to stay with us for a little while, then it is likely that ethane and propane move down. Look, you know Jack Broodo and Keith Cleason, they're looking at our feed slate on a normal basis every week and at basis like what happened in the last 72 hours on a daily basis. And so as you imagine, we're constantly shifting the feed slate to maximize cash. And that's how we look at it site by site, cracker by cracker, honestly, furnace by furnace.

Jeffrey Zekauskas

analyst
#12

Howard, I was wondering if you might discuss the state of Sadara and its financing. It was an asset that was built in a time of high oil prices and it suffered from lower oil prices and from slowness in global demand. There are some financing issues that are there. Can you give us an idea of what the puts and takes are as far as Sadara goes with Dow now?

Howard Ungerleider

executive
#13

Yes, sure, Jeff. I would say this, that Sadara is, from an asset perspective, it is a great asset. It's world-class technology, 26-unit operations, some of the only technology in the kingdom for the first time. We're running the asset hard. I would say -- with that said, Sadara is not immune to the margin compression that Dow has seen, our other joint ventures have seen, and all of our sector peers have seen, especially in the polyolefins area and the isocyanates and polyurethanes area. And that's really what's contributed to the additional drop in equity earnings related to Sadara. Where we sit today, both, I would say, Dow, and our partner, Saudi Aramco, remain committed to Sadara. We have completed the lender reliability test. We have one remaining agreement, logistics agreement, in the kingdom that Sadara needs to sign inside the kingdom before we can achieve project completion. We have agreement in principle between Sadara, the rail provider as well as Saudi Aramco and Dow. We are waiting for signatures. We don't have signatures yet, but I expect that to happen imminently. And then once that happens, then the next step that will probably take the balance of the year is we will work together with Sadara and Saudi Aramco and the lenders to reprofile the debt. We're looking to give Sadara some time to become cash flow self-sufficient so that they can continue to take their cost out, so that they can continue to ramp and sell up the production. I mean one of the downsides of starting up a mega project, 26 world-scale unit operations all within a matter of 18 months, is you tend to sell that up on the largest volume, which typically is the lowest unit value or unit return sales. And so this is something that is standard Dow practice that we're also working with each of our joint ventures, and Sadara is no different. But every product director, anybody who has a P&L looks at their margin velocity per reactor hour or per hour of production. And every quarter, they look to trim their fourth quartile on that basis and try to add volume or revenue that's in the first or second quartile. And so we want to give Sadara that time to be able to get their margins improving. And then, of course, a little bit of time will also help with the overall economic cycle as well, no doubt.

Jeffrey Zekauskas

analyst
#14

So your expectation is that Dow will complete -- or the Sadara will complete its rail agreement, and then sometime in the course of 2019, its debt will be restructured for the future? Is that your base case?

Howard Ungerleider

executive
#15

Yes. I would say, base case is, while I can't guarantee it, my base case is that the signatures on that rail agreement will happen before the end of the quarter, and then we will go into discussions with the lenders. I don't like to use the word restructure. We're not asking -- we will not ask the lenders to take a haircut. But we prefer the term reprofile so we'll be working with the lenders to adjust the tenors and/or to adjust the amortization schedule to give Sadara that time.

Jeffrey Zekauskas

analyst
#16

Howard, can you talk a little bit about the global urethanes or MDI market, in that it was a very profitable market a couple of years ago. Last year, it experienced slower demand and price pressure. It looked like things were strengthening but then maybe things softened toward the end of the year. Do you have a point of view of how urethanes and MDI will act this year? And is it different in different geographies?

Howard Ungerleider

executive
#17

Yes, sure, Jeff. I mean I think look, I think the world has a lot of things that cycle today. So you think it's -- and isocyanates or polyurethanes are no different. But really, if you think about -- they're a large supplier, isocyanate is a large supplier to big ticket durable items, whether it's refrigeration, whether it's homes or whether it's transportation, mobility. So I mean if you have a pullback in demand or production on new vehicle production, you're going to see that back up into isocyanates. And I think you've seen that happen in infrastructure-related markets last year and transportation markets. And I think that's what's really caused the drop-off in margins. Yes, in 2017 and first half of 2018, we really had fly-up margins. There was a really robust economic activity across all of those downstream markets that was pulling on isocyanate, and we had several across-the-sector production outages, which led to, let's say, above -- above normalized margins. And then I think we flagged that in Investor Day of at least $500 million that would come out. And then what we didn't expect is it coming down to breakeven economics at the marginal producer, which we've seen from a sector perspective, pretty much across polyolefins, isocyanates and even siloxanes. So at the end of last year, you had the marginal high-cost producer at breakeven or negative margins. MDI spreads over benzene. MDI pricing is, I think, the lowest it's been in more than a decade. And so is it likely that it goes lower from here? Perhaps, depending on your point of view of oil and the flow-through to propylene and benzene and their derivatives. But I would say, what you already started to see prior to COVID is people delaying or canceling new projects and people, both in China as well as in the U.S. Gulf, shutting some capacity. And that is typical of -- I mean, look, I've been with Dow 30 years. At this point in the economic or petrochemical cycle, when you've got the high-cost incremental producer at breakeven or negative cash, 1 of 2 things has to happen. Either you get a little bit of air in the hose and so they get pricing up that allows them to get back to breakeven or the next time they have to make a cash decision on a maintenance spend, the turnaround spend, any kind of an issue where they're going to have to put a large chunk of cash in, they will typically decide not to, and then either mothball that capacity or they will shut it down. In the last -- in the financial crisis, you saw on polyolefins, you saw 4 million metric tons of capacity come out. 2 million of it came out permanently. 2 million of it was idled or mothballed and then came back into the grid between 2012 and 2014. So I think whether it's isocyanates or siloxanes or polyolefins, you're in that same kind of a mode right now where I would call it bouncing along the bottom.

Jeffrey Zekauskas

analyst
#18

Howard, if I can ask you some general orientation questions about Dow Chemical now. Dow Chemical was part of DuPont or DowDuPont. And in that period of time, there were various assets that moved from Dow over to DuPont that were more specialized in engineering materials and silicones. And I had thought that the direction of Dow Chemical pre-DowDuPont merger was that the company wanted to be a more differentiated company, a more specialized company, a company with longer-term stronger growth characteristics. Now with those businesses having moved over, do you have to reset your strategy, that is, do you move more to an upstream focus? Or do you try to rebuild what it was that you created before? How is Dow situated differently strategically after those assets having moved over to DuPont?

Howard Ungerleider

executive
#19

Yes. Look, Jeff, I think it's a great question. I think the strategy from a Dow perspective is the same strategy that we announced at spin, right? I mean, what is the new Dow? The new Dow is -- our focus, our ambition is to be the most innovative, most customer-centric, most inclusive and most sustainable material science company in the world. We participate in 3, and increasingly, 4 market verticals: packaging materials, infrastructure materials, home and personal care materials. Those are the big 3. And we also have about $2 billion of revenue targeted at the mobility or the transportation market vertical. When you add those market verticals up, they're conservatively, and I'm saying in a very conservative definition, you've got $400 billion of market opportunity today. And if you say, we're about a $40 billion or $45 billion turnover revenue company, we only have a 10% share of our market today. So plenty of room for growth. But then the exciting part is those markets are growing at, at least 1.5x global GDP. And so our goal is to try and be the most -- we want to have operational -- operationally excellent execution, and we want to deliver new products and new applications for those market verticals, to those value chains to continue to grow our enterprise from a value creation standpoint, right? We don't -- doesn't necessarily mean we have to be the biggest, but we certainly want to be the most value-creating enterprise that touches materials science in those 3 or 4 market verticals. And I would tell you, that's why I get up every day, and that's what gets me excited to be a part of team Dow.

Jeffrey Zekauskas

analyst
#20

So when we look at DuPont, DuPont is doing reverse Morris Trust transactions, various separations. Is that something that also Dow could do? That is, you have adhesives operations, you have urethane operations. Are there opportunities for those types of combinations? Or is it really more the case that Dow wants to stay an integral entity?

Howard Ungerleider

executive
#21

I would say we have done those things. I mean, you've been with us every step of the way. When I think about the Styron transaction that created Trinseo; when I think about the RMT transaction that created Olin, the new Olin, I should say, to be fair to them; when I think about the tax-efficient restructuring of the ownership of Dow Corning; all of those things helped us to deliver, plus the merge and spin with DuPont that brought the ethylene copolymers business from DuPont. And so we're very happy with the portfolio we have. We are -- you saw one of our priorities is a best owner mindset. So I would say we're continuing to look at clean ups. We did some cleanup last year. We'll continue to do cleanup this year. That's probably in the -- last year was in the millions of dollars. I think when we look at benchmarking, it's a possibility that we'll have some infrastructure assets that we'll look to see if we are the best owner of versus somebody else, and that could be another series of transactions that happen over the next few years. But we like the portfolio we have. They're growth markets. We have best-in-class technology, whether that's process chemistry, catalyst, comonomer. The hybrid chemistry opportunity alone, we're the only silicone player that has olefins and propylene and urethanes and acrylics. And we're the only olefins player and polyurethanes player that has silicones. So our ability to take hybrid chemistry between silicones and C2, C3 derivatives, that's not going to move the needle next quarter, Jeff. But for the next 10 years, I think there's real opportunity for us to grow in those market verticals and deliver unique hybrid molecules that deliver performance-like silicones, more of the cost of the carbon molecule.

Jeffrey Zekauskas

analyst
#22

So maybe as a final question, Howard, can you give us an update on your ethylene expansion at Texas-9 and Freeport? Has that project come on stream? Will you have to turn off Texas-9 for a period of time in order to link up that production? And if you do, how long might that take?

Howard Ungerleider

executive
#23

Yes, it should be coming up from a startup or a beginning of a commissioning phase by the end of this month. And then probably by the time we get to the earnings call in late April, it should be in full startup mode. So I would say middle of the second quarter is probably a target for full startup at this point in time.

Jeffrey Zekauskas

analyst
#24

Okay. I very much appreciate doing the fireside chat with you, Howard. And I think with that, we'll close the call.

Howard Ungerleider

executive
#25

Me too, Jeff. Thanks for the time. Next time, in person, okay?

Jeffrey Zekauskas

analyst
#26

I look forward to it, Howard. Take care.

Howard Ungerleider

executive
#27

You, too. See you.

Jeffrey Zekauskas

analyst
#28

This closes our call.

Operator

operator
#29

That concludes today's conference. Thank you for participating, you may disconnect at this time.

This call discussed

For developers and AI pipelines

Programmatic access to Dow Inc. earnings transcripts and 32,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.